APA (7th ed.) Citation

Chylińska, M., Komendziński, J., Wyszomirski, A., & Karaszewski, B. (2023). Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis. Multiple sclerosis international, 2023, 1-11. https://doi.org/10.1155/2023/4130557

Chicago Style (17th ed.) Citation

Chylińska, Magdalena, Jakub Komendziński, Adam Wyszomirski, and Bartosz Karaszewski. "Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis." Multiple Sclerosis International 2023 (2023): 1-11. https://doi.org/10.1155/2023/4130557.

MLA (9th ed.) Citation

Chylińska, Magdalena, et al. "Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis." Multiple Sclerosis International, vol. 2023, 2023, pp. 1-11, https://doi.org/10.1155/2023/4130557.